Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Receivables: 2020-2021

Historic Receivables for Fulcrum Therapeutics (FULC) over the last 2 years, with Dec 2021 value amounting to $3.6 million.

  • Fulcrum Therapeutics' Receivables was N/A to $803,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $8.1 million, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2021, which is 43.70% up from last year.
  • Fulcrum Therapeutics' Receivables amounted to $3.6 million in FY2021, which was up 43.70% from $2.5 million recorded in FY2020.
  • Over the past 5 years, Fulcrum Therapeutics' Receivables peaked at $3.6 million during FY2021, and registered a low of $2.5 million during FY2020.
  • In the last 2 years, Fulcrum Therapeutics' Receivables had a median value of $3.1 million in 2020 and averaged $3.1 million.
  • Data for Fulcrum Therapeutics' Receivables shows a peak YoY soared of 43.70% (in 2021) over the last 5 years.
  • Fulcrum Therapeutics' Receivables (Yearly) stood at $2.5 million in 2020, then soared by 43.70% to $3.6 million in 2021.